biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by lamystiqueon Nov 16, 2001 2:03pm

2594 Views

Post# 4414629

Motorola Deal?

If there is any speculation, then it would have to be a company like Motorola which has a disposable cell phone coming out. This one is a 3G cell phone with video. After the battery is depleted, the cell phone is simply disposed of. So the only battery which could be used in the cell phone would have to be a 'rechargeable alkaline battery' which does not use mercury or cadmium, ie. Pure Energy, Rayovac, or something like that, a patented BTI rechargeable battery. Anyway I will look for the news item from Motorola which will use this battery. Of course maybe Ericsson is going to use the demacell rechargeable BTI battery.....lets see... lamy

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading